These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4102421)

  • 1. Pregnancy and serum-creatine-kinase levels in potential carriers of Duchenne X-linked muscular dystrophy.
    Emery AE; King B
    Lancet; 1971 May; 1(7707):1013. PubMed ID: 4102421
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of exercise on serum creatine kinase in carriers of Duchenne muscular dystrophy.
    Gaines RF; Pueschel SM; Sassaman EA; Driscoll JL
    J Med Genet; 1982 Feb; 19(1):4-7. PubMed ID: 7069744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle histology and creatine kinase levels in the foetus in Duchenne muscular dystrophy.
    Emery AE
    Nature; 1977 Mar; 266(5601):472-3. PubMed ID: 859617
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum pyruvate-kinase (PK) activity during pregnancy in potential carriers for Duchenne muscular dystrophy.
    Zatz M; Passos MR; Bortolini ER
    Am J Med Genet; 1983 May; 15(1):149-51. PubMed ID: 6859115
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of creatine kinase for detecting severe X-linked muscular dystrophy carriers.
    Dennis NR; Evans K; Clayton B; Carter CO
    Br Med J; 1976 Sep; 2(6035):577-9. PubMed ID: 963439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy and serum C.P.K. levels in potential carriers of severe X-linked muscular dystrophy.
    Blyth H; Hughes BP
    Lancet; 1971 Apr; 1(7704):855-6. PubMed ID: 4102542
    [No Abstract]   [Full Text] [Related]  

  • 7. Carrier detection in Duchenne muscular dystrophy: Assessment of the effect of age on detection-rate with serum-creatine-kinase-activity.
    Nicholson GA; Gardner-Medwin D; Pennington RJ; Walton JN
    Lancet; 1979 Mar; 1(8118):692-4. PubMed ID: 85935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dilution effect on serum creatine kinase in carriers of Duchenne muscular dystrophy.
    Simpson AC; Holmes D; Pennington RJ
    Ann Clin Biochem; 1979 Jan; 16(1):54-5. PubMed ID: 420506
    [No Abstract]   [Full Text] [Related]  

  • 9. Carrier detection in X-linked recessive (Duchenne) muscular dystrophy: serum creatine phosphokinase values in premenarchal, menstruating, postmenopausal and pregnant normal women.
    Smith I; Elton RA; Thomson WH
    Clin Chim Acta; 1979 Nov; 98(3):207-16. PubMed ID: 498534
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of discriminant analysis of serum creatine kinase levels for detection of heterozygote carriers of Duchenne muscular dystrophy].
    Krasil'nikov VV; Labeznik TA; Shilov LA
    Genetika; 1987 Jan; 23(1):176-9. PubMed ID: 3817468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Creatine phosphokinase activity in serum of carriers of progressive muscular dystrophy of Duchenne type].
    Barthelmai W; Dikbas G; Wüllner S
    Humangenetik; 1969 Oct; 8(2):115-33. PubMed ID: 5365581
    [No Abstract]   [Full Text] [Related]  

  • 12. Variability of serum creatine phosphokinase activity in normal women and carriers of the gene for Duchenne muscular dystrophy.
    Perry TB; Fraser FC
    Neurology; 1973 Dec; 23(12):1316-23. PubMed ID: 4796611
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum pyruvate kinase in carriers of Duochenne muscular dystrophy.
    Yamuna S; Valmikinathan K; Burt D; Emery AE
    Clin Chim Acta; 1977 Aug; 79(1):277-9. PubMed ID: 890959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum creatine kinase activity and carrier status for duchenne muscular dystrophy.
    Bullock DG; McSweeney FM; Whitehead TP; Edwards JH
    Lancet; 1979 Dec 22-29; 2(8156-8157):1370. PubMed ID: 92710
    [No Abstract]   [Full Text] [Related]  

  • 15. A new method for the analysis of age trends in CPK levels with application to Duchenne muscular dystrophy.
    Lange K; Zatz M
    Hum Hered; 1979; 29(3):154-60. PubMed ID: 468274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of the creatine kinase test in the detection of carriers of Duchenne muscular dystrophy.
    Thompson MW; Murphy EG; McAlpine PJ
    J Pediatr; 1967 Jul; 71(1):82-93. PubMed ID: 5293863
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum LDH-5 in carriers of Duchenne muscular dystrophy.
    Burt D; Emery AE
    Neurology; 1979 Feb; 29(2):239-41. PubMed ID: 571069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of carrier detection of Duchenne muscular dystrophy using carbonic anhydrase III and creatine kinase.
    Heath R; Carter ND; Jeffery S; Edwards RJ; Watts DC; Watts RL
    Am J Med Genet; 1985 Jun; 21(2):291-6. PubMed ID: 3925781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of creatine kinase in sera from healthy women, carriers of Duchenne muscular dystrophy and cord blood, determined by the "European" recommended method with NAC-EDTA activation.
    Moss DW; Whitaker KB; Parmar C; Heckmatt J; Wikowski J; Sewry C; Dubowitz V
    Clin Chim Acta; 1981 Oct; 116(2):209-16. PubMed ID: 6794955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum creatine kinase studies in the detection of carriers of Duchenne dystrophy.
    Hughes RC; Park DC; Parsons ME; O'Brien MD
    J Neurol Neurosurg Psychiatry; 1971 Oct; 34(5):527-30. PubMed ID: 4941478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.